Is Alzheimer's disease a mitochondrial disorder?

被引:31
|
作者
Cash, AD [1 ]
Perry, G [1 ]
Ogawa, O [1 ]
Raina, AK [1 ]
Zhu, XW [1 ]
Smith, MA [1 ]
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
来源
NEUROSCIENTIST | 2002年 / 8卷 / 05期
关键词
Alzheimer's disease; amyloid-beta; antioxidants; free radicals; mitochondria; neurodegeneration;
D O I
10.1177/107385802236968
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cell bodies of neurons at risk of death in Alzheimer's disease (AD) have increased lipid peroxidation, nitration, free carbonyls, and nucleic acid oxidation. These oxidative changes occur in all vulnerable neurons and are reduced in neurons that contain neurofibrillary pathology. In this review, the authors provide a summary of recent work that demonstrates key abnormalities that may play a part in initiating and promoting neuronal oxidative damage. Mitochondrial abnormalities are clearly involved as a source of reactive oxygen species that culminates in perikaryal oxidative damage. However, because mitochondria in AD do not exhibit striking evidence of oxidative damage, as would be expected if they produced free radicals directly, the authors suspected that abnormal mitochondria are responsible for supplying a key reactant, that once in the cytoplasm, releases radicals. Because abnormal mitochondria, H2O2 and redox-active iron are juxtaposed in the same AD neuron, it has all the markings of a "radical factory." The proximal causes of mitochondrial abnormalities likely involve reentry into the cell cycle, where organellokinesis and proliferation results in an increase of mitochondria and intermediately differentiated cells, with a consequent increase in turnover. Supporting this, the authors have considerable in vivo and in vitro evidence for mitotic disturbances in AD.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [31] Mitochondrial aging and dysfunction in Alzheimer's disease
    Sullivan, PG
    Brown, MR
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (03): : 407 - 410
  • [32] Mitochondrial DNA variation in Alzheimer's disease
    Maruszak, Aleksandra
    Safranow, Krzysztof
    Gaweda-Walerych, Katarzyna
    Gabryelewicz, Tomasz
    Canter, Jeffrey A.
    Barcikowska, Maria
    Zekanowski, Cezary
    PHARMACOLOGICAL REPORTS, 2011, 63 (05) : 1278 - 1278
  • [33] Mitochondrial dysfunction in models of Alzheimer's disease
    Eckert, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 23 - 23
  • [34] Mitochondrial alterations in synapses in Alzheimer's disease
    Baloyannis, S. J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 283 (1-2) : 283 - 283
  • [35] Synaptic Mitochondrial Pathology in Alzheimer's Disease
    Du, Heng
    Guo, Lan
    Yan, Shirley ShiDu
    ANTIOXIDANTS & REDOX SIGNALING, 2012, 16 (12) : 1467 - 1475
  • [36] Mitochondrial calcium overload in alzheimer's disease
    Jadiya, P.
    Tomar, D.
    Elrod, J.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 697 - 697
  • [37] Mitochondrial Perturbation in Alzheimer's Disease and Diabetes
    Akhter, F.
    Chen, D.
    Yan, S. F.
    Yan, S. S.
    MOLECULAR BIOLOGY OF AGING, 2017, 146 : 341 - 361
  • [38] ABNORMAL MITOCHONDRIAL DYNAMICS IN ALZHEIMER'S DISEASE
    Zhu, X.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 68 - 68
  • [39] The mitochondrial epigenome: a role in Alzheimer's disease?
    Devall, Matthew
    Mill, Jonathan
    Lunnon, Katie
    EPIGENOMICS, 2014, 6 (06) : 665 - 675
  • [40] Mitochondrial Genome Variants and Alzheimer's Disease
    Kozin, Maxim S.
    Kulakova, Olga G.
    Kiselev, Ivan S.
    Semina, Ekaterina V.
    Kakotkin, Viktor V.
    Agapov, Mikhail A.
    Favorova, Olga O.
    BIOCHEMISTRY-MOSCOW, 2025, 90 (SUPPL1) : S146 - S163